Publicacións nas que colabora con RUBÉN CEBRIÁN CASTILLO (37)

2024

  1. Uncovering the diversity and distribution of biosynthetic gene clusters of prochlorosins and other putative RiPPs in marine Synechococcus strains

    Microbiology Spectrum, Vol. 12, Núm. 1

2023

  1. Advances in the preclinical characterization of the antimicrobial peptide AS-48

    Frontiers in Microbiology, Vol. 14

  2. Investigating the Specificity of the Dehydration and Cyclization Reactions in Engineered Lanthipeptides by Synechococcal SyncM

    ACS Synthetic Biology, Vol. 12, Núm. 1, pp. 164-177

  3. Real-life validation of a sample pooling strategy for screening of hepatitis C

    Clinical Microbiology and Infection, Vol. 29, Núm. 1, pp. 112.e1-112.e4

  4. Synthesis and antimicrobial activity of aminoalkyl resveratrol derivatives inspired by cationic peptides

    Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 38, Núm. 1, pp. 267-281

2022

  1. Chemically Tuning Resveratrol for the Effective Killing of Gram-Positive Pathogens

    Journal of Natural Products, Vol. 85, Núm. 6, pp. 1459-1473

  2. G-Quadruplex DNA as a Target in Pathogenic Bacteria: Efficacy of an Extended Naphthalene Diimide Ligand and Its Mode of Action

    Journal of Medicinal Chemistry, Vol. 65, Núm. 6, pp. 4752-4766

2021

  1. Antimicrobial activity of the circular bacteriocin as-48 against clinical multidrug-resistant staphylococcus aureus

    Antibiotics, Vol. 10, Núm. 8

  2. Elucidating the mechanism by which synthetic helper peptides sensitize Pseudomonas aeruginosa to multiple antibiotics

    PLoS Pathogens, Vol. 17, Núm. 9

  3. Functional Expression and Characterization of the Highly Promiscuous Lanthipeptide Synthetase SyncM, Enabling the Production of Lanthipeptides with a Broad Range of Ring Topologies

    ACS Synthetic Biology, Vol. 10, Núm. 10, pp. 2579-2591

  4. Outer-membrane-acting peptides and lipid II-targeting antibiotics cooperatively kill Gram-negative pathogens

    Communications Biology, Vol. 4, Núm. 1

  5. The cathelicidin-derived close-to-nature peptide D-11 sensitises Klebsiella pneumoniae to a range of antibiotics in vitro, ex vivo and in vivo

    International Journal of Antimicrobial Agents, Vol. 58, Núm. 5

2020

  1. Assessing the effectiveness of AS-48 in experimental mice models of Chagas' disease

    Journal of Antimicrobial Chemotherapy, Vol. 75, Núm. 6, pp. 1537-1545

  2. High-Throughput Screening for Substrate Specificity-Adapted Mutants of the Nisin Dehydratase NisB

    ACS Synthetic Biology, Vol. 9, Núm. 6, pp. 1468-1478

  3. Role of maltodextrin and inulin as encapsulating agents on the protection of oleuropein during in vitro gastrointestinal digestion

    Food Chemistry, Vol. 310

  4. Synergy of the bacteriocin AS-48 and antibiotics against uropathogenic enterococci

    Antibiotics, Vol. 9, Núm. 9, pp. 1-15

2019

  1. Design and Expression of Specific Hybrid Lantibiotics Active Against Pathogenic Clostridium spp.

    Frontiers in Microbiology, Vol. 10

  2. Evolution of the phenolic compounds profile of olive leaf extract encapsulated by spray-drying during in vitro gastrointestinal digestion

    Food Chemistry, Vol. 279, pp. 40-48

  3. Insights into Chagas treatment based on the potential of bacteriocin AS-48

    International Journal for Parasitology: Drugs and Drug Resistance, Vol. 10, pp. 1-8

  4. Preclinical studies of toxicity and safety of the AS-48 bacteriocin

    Journal of Advanced Research, Vol. 20, pp. 129-139